Best Path Forward for Successful Product Development
Tuesday, November 12 | 11:15am-12:00pm
Moderator: Martin Gouldstone, Global SVP, Syneos One
Andrew Hotchkiss, CCO, Immunocore Sean Marett, CBO and COO, BioNTech Hartmut Juhl, Founder and CEO, Indivumed Group
Grace Colon, CEO & President, InCarda Therapeutics
Clinical development, product approval, patient compliance, improved outcomes, and a value-based system all depend on innovative, successful product differentiation to address unmet medical needs. This session will explore the use of real-world evidence and other resources that can provide advantages from de-risking drug development to paving the way for positive clinical trials to launching new therapies. Industry experts share their insights on ways to leverage the ever expanding opportunities to use RWE
